| Current Price | $2.63 | Mkt Cap | $125.0M |
|---|---|---|---|
| Open | $2.67 | P/E Ratio | -47.39 |
| Prev. Close | $2.63 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.60 - $2.74 | Volume | 105,881 |
| 52-Wk Range | $2.08 - $5.16 | Avg. Daily Vol. | 156,068 |
| Current Price | $2.63 | Mkt Cap | $125.0M |
|---|---|---|---|
| Open | $2.67 | P/E Ratio | -47.39 |
| Prev. Close | $2.63 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.60 - $2.74 | Volume | 105,881 |
| 52-Wk Range | $2.08 - $5.16 | Avg. Daily Vol. | 156,068 |
The best Bull and Bear pitches based on recency and number of recommendations.
I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one… More
Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.
Read the most recent pitches from players about PBYI.
Recs
TMFEBCapital
(74.42)
Submitted: 7/6/2018 3:45:30 PM :
Start Price:
$59.65
NASDAQ:PBYI Score:
-151.04
I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one makes sense to buy here.
Recs
foolsgold83
(< 20)
Submitted: 12/7/2017 12:57:33 AM :
Start Price:
$98.30
NASDAQ:PBYI Score:
-159.81
Prior success with leadership. Successfully bringing approved drugs to market. Will either continue to grow with successful trials or be acquired.
Recs
YourDailyBear
(42.75)
Submitted: 1/14/2016 1:28:07 PM :
Start Price:
$49.32
NASDAQ:PBYI Score:
+217.17
Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.
Find the members with the highest scoring picks in PBYI.
IBDContrarian (65.98) Score: +266.82
The Score Leader is the player with the highest score across all their picks in PBYI.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| IBDContrarian | 65.98 | 4/8/2013 |
|
5Y | $30.95 | -91.50% | +175.31% | +266.82 | 1 Comment | |
| kevrose31 | 79.18 | 1/10/2014 |
|
1Y | $110.14 | -97.61% | +132.39% | +230.00 | 0 Comment | |
| SimonSaysSell | 98.86 | 4/16/2014 |
|
NS | $73.01 | -96.40% | +130.48% | +226.88 | 0 Comment | |
| sobek1 | 77.90 | 8/6/2014 |
|
1Y | $230.97 | -98.86% | +123.68% | +222.54 | 0 Comment | |
| YourDailyBear | 42.75 | 1/14/2016 |
|
1Y | $49.32 | -94.67% | +122.51% | +217.17 | 1 Comment | |
| jayningpan | 63.67 | 8/18/2014 |
|
5Y | $262.01 | -99.00% | +116.77% | +215.77 | 0 Comment | |
| bumpyjr | 21.62 | 7/23/2014 |
|
5Y | $230.35 | -98.86% | +115.16% | +214.02 | 0 Comment | |
| jackbot | 98.28 | 7/24/2014 |
|
5Y | $214.06 | -98.77% | +115.15% | +213.92 | 0 Comment | |
| theMetz | 23.91 | 7/24/2014 |
|
1Y | $226.00 | -98.84% | +115.00% | +213.83 | 0 Comment | |
| newbie07 | 75.45 | 7/24/2014 |
|
5Y | $226.00 | -98.84% | +115.00% | +213.83 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
